MUTATION AT THE HPRT LOCUS IN PATIENTS WITH NEUROCYSTICERCOSIS TREATED WITH PRAZIQUANTEL

Citation
R. Montero et al., MUTATION AT THE HPRT LOCUS IN PATIENTS WITH NEUROCYSTICERCOSIS TREATED WITH PRAZIQUANTEL, MUTATION RESEARCH, 305(2), 1994, pp. 181-188
Citations number
32
Categorie Soggetti
Genetics & Heredity",Toxicology
Journal title
ISSN journal
00275107
Volume
305
Issue
2
Year of publication
1994
Pages
181 - 188
Database
ISI
SICI code
0027-5107(1994)305:2<181:MATHLI>2.0.ZU;2-Z
Abstract
Praziquantel (PZQ) is the drug of choice in the treatment of neurocyst icercosis (NC), a parasitic disease caused by Taenia solium larvae. Va riant frequencies at the hprt locus were analyzed in a group of NC pat ients before and after treatment with PZQ as well as in two control gr oups: healthy donors and non-parasitic neurological patients. Data sho w that PZQ does no induce hprt mutations, but that cysticerci by thems elves or together with palliative treatment administered to NC patient s could induce mutations in some patients.